1h Free Analyst Time
The publisher has been monitoring the cervical dystonia therapeutics market and it is poised to grow by $154.77 mn during 2021-2025, progressing at a CAGR of 5.43% during the forecast period. The report on the cervical dystonia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the expected approval of late-stage pipeline molecules and increasing awareness about cervical dystonia.
The cervical dystonia therapeutics market analysis includes the product segment and geographic landscape.
The cervical dystonia therapeutics market is segmented as below:
By Product
- Botulinum toxins
- Other therapeutics
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the rising middle-age group population as one of the prime reasons driving the cervical dystonia therapeutics market growth during the next few years.
The report on cervical dystonia therapeutics market covers the following areas:
- Cervical dystonia therapeutics market sizing
- Cervical dystonia therapeutics market forecast
- Cervical dystonia therapeutics market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cervical dystonia therapeutics market vendors that include AbbVie Inc., Akorn Inc., Eisai Co. Ltd., Galderma SA, Ipsen Pharma, Lannett Co. Inc., Medytox Inc., Merz Pharma GmbH and Co. KGaA, Revance Therapeutics Inc., and Supernus Pharmaceuticals Inc. Also, the cervical dystonia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value Chain Analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Botulinum toxins - Market size and forecast 2020-2025
- Other therapeutics - Market size and forecast 2020-2025
- Market opportunity by Product
Customer landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW- Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
Drivers, Challenges, and Trends
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
- Competitive Scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- AbbVie Inc.
- Akorn Inc.
- Eisai Co. Ltd.
- Galderma SA
- Ipsen Pharma
- Lannett Co. Inc.
- Medytox Inc.
- Merz Pharma GmbH and Co. KGaA
- Revance Therapeutics Inc.
- Supernus Pharmaceuticals Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research Methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Product - Market share 2020-2025 (%)
- Comparison by Product
- Botulinum toxins - Market size and forecast 2020-2025 ($ million)
- Botulinum toxins - Year-over-year growth 2020-2025 (%)
- Other therapeutics - Market size and forecast 2020-2025 ($ million)
- Other therapeutics - Year-over-year growth 2020-2025 (%)
- Market opportunity by Product
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Key customers
- AbbVie Inc. - Segment focus
- Akorn Inc. - Overview
- Akorn Inc. - Product and service
- Akorn Inc. - Key offerings
- Akorn Inc. - Key customers
- Akorn Inc. - Segment focus
- Eisai Co. Ltd. - Overview
- Eisai Co. Ltd. - Business segments
- Eisai Co. Ltd. - Key offerings
- Eisai Co. Ltd. - Key customers
- Eisai Co. Ltd. - Segment focus
- Galderma SA - Overview
- Galderma SA - Product and service
- Galderma SA - Key offerings
- Galderma SA - Key customers
- Galderma SA - Segment focus
- Ipsen Pharma - Overview
- Ipsen Pharma - Business segments
- Ipsen Pharma - Key offerings
- Ipsen Pharma - Key customers
- Ipsen Pharma - Segment focus
- Lannett Co. Inc. - Overview
- Lannett Co. Inc. - Business segments
- Lannett Co. Inc. - Key offerings
- Lannett Co. Inc. - Key customers
- Lannett Co. Inc. - Segment focus
- Medytox Inc. - Overview
- Medytox Inc. - Business segments
- Medytox Inc. - Key offerings
- Medytox Inc. - Key customers
- Medytox Inc. - Segment focus
- Merz Pharma GmbH and Co. KGaA - Overview
- Merz Pharma GmbH and Co. KGaA - Product and service
- Merz Pharma GmbH and Co. KGaA - Key offerings
- Merz Pharma GmbH and Co. KGaA - Key customers
- Merz Pharma GmbH and Co. KGaA - Segment focus
- Revance Therapeutics Inc. - Overview
- Revance Therapeutics Inc. - Product and service
- Revance Therapeutics Inc. - Key offerings
- Revance Therapeutics Inc. - Key customers
- Revance Therapeutics Inc. - Segment focus
- Supernus Pharmaceuticals Inc. - Overview
- Supernus Pharmaceuticals Inc. - Business segments
- Supernus Pharmaceuticals Inc. - Key offerings
- Supernus Pharmaceuticals Inc. - Key customers
- Supernus Pharmaceuticals Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global cervical dystonia therapeutics market: AbbVie Inc., Akorn Inc., Eisai Co. Ltd., Galderma SA, Ipsen Pharma, Lannett Co. Inc., Medytox Inc., Merz Pharma GmbH and Co. KGaA, Revance Therapeutics Inc., and Supernus Pharmaceuticals Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising middle-age group population.'
According to the report, one of the major drivers for this market is the expected approval of late-stage pipeline molecules.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Akorn Inc.
- Eisai Co. Ltd.
- Galderma SA
- Ipsen Pharma
- Lannett Co. Inc.
- Medytox Inc.
- Merz Pharma GmbH and Co. KGaA
- Revance Therapeutics Inc.
- Supernus Pharmaceuticals Inc.
